A REVIEW OF ALLOGRAFT PROCESSING AND STERILIZATION TECHNIQUES AND THEIR ROLE IN TRANSMISSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS

被引:134
作者
ASSELMEIER, MA
CASPARI, RB
BOTTENFIELD, S
机构
[1] Orthopaedic Research of Virginia, Richmond
[2] LifeNet Transplant Services, Virginia, Virginia Beach
关键词
D O I
10.1177/036354659302100202
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Human immunodeficiency virus (HIV) infection via vascular organ and tissue transplantation is well documented. The majority of these transmissions occurred before the development of HIV antibody testing, which is now a routine screening tool used before organ and tissue procurement and transplantation. There exists what is commonly referred to as a ''window'' of sero-negativity after HIV infection. Potential donors may be infectious with the HIV virus but not yet detected with available HIV antibody tests. Bone and soft tissue retrieval may be done in either a sterile or clean, non-sterile manner. Deep freezing and freeze-drying (lyophilization) are two commonly used modes of preserving bone and soft tissue allografts. In 1985, a screened donor who was in the window of seronegativity underwent vascular organ and musculoskeletal tissue harvest. The bone and soft tissue procured underwent a variety of processing and preservation techniques. There have been no known cases of HIV transmission from the processed freeze-dried tissues. Evidence now exists that early HIV infection, before HIV antibody production, may be the most infectious period. The HIV antigen testing may allow earlier detection of an infectious donor, thus closing the window of seronegativity. It is unknown whether this nontransmission of HIV to the recipients of the processed and freeze-dried tissue was due to the processing or the nature of the tissue itself.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 37 条
  • [1] MMWR, 33, pp. 589-591, (1984)
  • [2] Albert J., Gaines H., Sonnerborg A., Et al., Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection, J Med Virol, 23, pp. 67-73, (1987)
  • [3] Alter H., Epstein J., Swenson S., Et al., Prevalence of human immunodeficiency virus type I p24 antigen in U.S. blood donors—an assessment of the efficacy of testing in donor screening, N Engl J Med, 323, pp. 1312-1317, (1990)
  • [4] Buck B., Malinin T., Clin Orthop, 240, pp. 129-136, (1989)
  • [5] Buck B., Resnick L., Shah S., Et al., Human immunodeficiency virus cultured from bone: Implications for transplantation, Clin Orthop, 251, pp. 249-253, (1990)
  • [6] Busch M., Taylor P., Lenes B., Et al., Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type I, New Engl J Med, 323, pp. 1308-1312, (1990)
  • [7] Butler D., Noyes F., Walz K., Et al., Biomechanics of human knee ligament allograft treatment, Trans Orthop Res Soc, 12, (1987)
  • [8] Came C., Tedder R., Smith A., Et al., Acute encephalopathy coincident with seroconversion for anti-HTLV-III, Lancet, 2, pp. 1206-1208, (1985)
  • [9] Conway B., Tomford W., Mankin H., Et al., Radiodensity of HIV—1—potential application to sterilization, AIDS, 5, pp. 608-609, (1991)
  • [10] Daar E., Moudgil T., Meyer R., Et al., Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection, New Engl J Med, 324, pp. 961-964, (1991)